Acutus Medical, Inc. Appoints New Chief Financial Officer and New Board Member
February 09 2021 - 4:01PM
Acutus Medical (Nasdaq: AFIB) today announced the appointment of
David Roman as the company’s Chief Financial Officer, effective
March 1, 2021. In addition, Daniella Cramp has joined the Company’s
board of directors, effective February 3, 2021.
“David is an accomplished executive with a
wealth of experience in healthcare, finance and strategy,” said
Vince Burgess, President and CEO. “His medical technology industry
expertise, operational background, and depth of relationships
within the investment community will strengthen our leadership team
and drive the continued execution of our strategic vision.”
Mr. Roman joins Acutus with over 15 years of
experience in the medical technology industry. Most recently, Mr.
Roman served as Vice President, Strategy and FP&A for Baxter
International, Inc., where Mr. Roman has held roles of increasing
responsibility since 2016. Prior to joining Baxter, Mr. Roman was a
managing director at Goldman, Sachs & Co., leading the firm’s
US medical technology equity research team. Mr. Roman began his
professional career in 2004 at Morgan Stanley, where he also
covered the medical technology sector as a research analyst.
Mr. Roman stated, “I am excited to join the
Acutus team on their mission to transform patients’ lives; the
company is bringing differentiated technology to the market and I
look forward to working with Vince and the entire organization to
lead the charge in the EP revolution.”
With Mr. Roman’s appointment, Gary Doherty will
transition from his role as Chief Financial Officer to Senior Vice
President, Finance within the company’s finance organization.
“Gary’s leadership through the early years of our company’s
development and during our initial public offering has enabled us
to build a strong foundation for growth,” commented Mr.
Burgess.
In addition to Mr. Roman’s appointment as Chief
Financial Officer, the Company is pleased to announce the
appointment of Daniella Cramp to its board of directors. Ms. Cramp
has over 25 years of experience in the medical device and
pharmaceutical industries, with particular expertise in the
cardiovascular industry. Since 2019, she has been with Thermo
Fisher Scientific, a scientific instruments equipment and supplies
company with annual revenue exceeding $25 billion, currently
serving as Senior Vice President and President, BioProduction
Group. Prior to her role with Thermo Fisher Scientific, Ms. Cramp
served as Global President for Johnson & Johnson’s (J&J’s)
neurovascular medical device business and as U.S. President for
Biosense Webster, J&J’s electrophysiology business.
"Daniella's knowledge of our industry and
leadership over high-performing commercial teams will greatly
benefit Acutus," said Mr. Burgess. “This expertise, coupled with
her successful management experience with well-established medical
device companies, makes Daniella an excellent addition to our
board."
"I am excited about joining the Acutus Medical
Board," stated Ms. Cramp. "I look forward to working alongside my
fellow board members and company management to continue advancing
the field of electrophysiology.”
“We look forward to David and Daniella
contributing to Acutus as we remain steadfast in our passion to
provide patient-focused solutions for the electrophysiology
community that help people live better lives,” concluded Mr.
Burgess.
About Acutus Medical Acutus
Medical is an arrhythmia management company focused on improving
the way cardiac arrhythmias are diagnosed and treated. Acutus is
committed to advancing the field of electrophysiology with a unique
array of products and technologies which will enable more
physicians to treat more patients more efficiently and effectively.
Through internal product development, acquisitions and global
partnerships, Acutus has established a global sales presence
delivering a broad portfolio of highly differentiated
electrophysiology products that provide its customers with a
complete solution for catheter-based treatment of cardiac
arrhythmias. Founded in 2011, Acutus is based in Carlsbad,
California.
Follow Acutus Medical on:
- Twitter: @AcutusMedical
- LinkedIn: www.linkedin.com/company/acutus-medical-inc-/
- Facebook: @AcutusMedical
Investor Contact:Caroline
CornerWestwicke ICRD:
415-314-1725Caroline.corner@westwicke.com
Holly WindlerM:
619-929-1275media@acutusmedical.com
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
From Sep 2023 to Sep 2024